Drug profile · INN
oxprenolol hydrochloride
TRASICOR
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
oxprenolol hydrochloride (TRASICOR) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN oxprenolol hydrochloride
Brand TRASICOR
Route ORAL
Formulation CAPSULE
Frequently asked questions
What is oxprenolol hydrochloride?
oxprenolol hydrochloride (TRASICOR) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for oxprenolol hydrochloride?
TRASICOR is a marketed brand name for oxprenolol hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of oxprenolol hydrochloride?
oxprenolol hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.